New data highlighting the efficacy and safety outcomes of third ‐generation EGFR‐TKI in NSCLC patients with rare EGFR mutations

Thoracic Cancer, EarlyView.

Source: Thoracic Cancer - January 27, 2020 Category: Cancer & Oncology Authors: Weisan Zhang, Fengtan Li, Wenyuan Gao Tags: EDITORIAL Source Type: research